NATIONAL CANCER INSTITUTE OF CANADA CLINICAL TRIALS GROUP How compliant are patients with oral hormonal therapies? Data from a randomized placebo controlled study of tamoxifen (T), after adjuvant chemotherapy (CT), in premenopausal women with early breast cancer (EBC):(NCIC CTG MA. 12)

作者： Vivien Bramwell , Kathleen Pritchard , Dongsheng Tu , Katia Tonkin , Haresh Vachhrajani

DOI:

关键词:

摘要: Objectives1. To compare duration of overall survival (OS) in premenopausal node positive* breast cancer patients given T vs P for 5 yrs after adjuvant CT

暂无可下载资源，当前可以选择系统获取到有开放资源时通知我或者直接发起求助文献求助

参考文章(0)

NATIONAL CANCER INSTITUTE OF CANADA CLINICAL TRIALS GROUP How compliant are patients with oral hormonal therapies? Data from a randomized placebo controlled study of tamoxifen (T), after adjuvant chemotherapy (CT), in premenopausal women with early breast cancer (EBC):(NCIC CTG MA. 12)

来源期刊

我的账户

NATIONAL CANCER INSTITUTE OF CANADA CLINICAL TRIALS GROUP How compliant are patients with oral hormonal therapies? Data from a randomized placebo controlled study of tamoxifen (T), after adjuvant chemotherapy (CT), in premenopausal women with early breast cancer (EBC):(NCIC CTG MA. 12)

来源期刊

相似文章 0

我的账户